<VariationArchive VariationID="2444489" VariationName="NM_006383.4(CIB2):c.476_479del (p.Asp159fs)" VariationType="Deletion" Accession="VCV002444489" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2023-03-26" MostRecentSubmission="2023-03-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2418219" VariationID="2444489">
      <GeneList>
        <Gene Symbol="CIB2" FullName="calcium and integrin binding family member 2" GeneID="10518" HGNC_ID="HGNC:24579" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="78104606" stop="78131535" display_start="78104606" display_stop="78131535" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="78396990" stop="78423877" display_start="78396990" display_stop="78423877" Strand="-" />
          </Location>
          <OMIM>605564</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006383.4(CIB2):c.476_479del (p.Asp159fs)</Name>
      <CanonicalSPDI>NC_000015.10:78105801:CCGTCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="78105802" stop="78105805" display_start="78105802" display_stop="78105805" variantLength="4" positionVCF="78105801" referenceAlleleVCF="ACCGT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="78398144" stop="78398147" display_start="78398144" display_stop="78398147" variantLength="4" positionVCF="78398143" referenceAlleleVCF="ACCGT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>D110fs</ProteinChange>
      <ProteinChange>D116fs</ProteinChange>
      <ProteinChange>D159fs</ProteinChange>
      <ProteinChange>D164fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.78105804_78105807del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.78105804_78105807del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.78398146_78398149del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.78398146_78398149del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033006.1" sequenceAccession="NG_033006" sequenceVersion="1" change="g.30731_30734del">
            <Expression>NG_033006.1:g.30731_30734del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033006.2" sequenceAccession="NG_033006" sequenceVersion="2" change="g.30730_30733del">
            <Expression>NG_033006.2:g.30730_30733del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271888.2" sequenceAccession="NM_001271888" sequenceVersion="2" change="c.347_350del">
            <Expression>NM_001271888.2:c.347_350del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258817.1" sequenceAccession="NP_001258817" sequenceVersion="1" change="p.Asp116fs">
            <Expression>NP_001258817.1:p.Asp116fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001271889.2" sequenceAccession="NM_001271889" sequenceVersion="2" change="c.329_332del">
            <Expression>NM_001271889.2:c.329_332del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001258818.1" sequenceAccession="NP_001258818" sequenceVersion="1" change="p.Asp110fs">
            <Expression>NP_001258818.1:p.Asp110fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001301224.2" sequenceAccession="NM_001301224" sequenceVersion="2" change="c.491_494del">
            <Expression>NM_001301224.2:c.491_494del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001288153.1" sequenceAccession="NP_001288153" sequenceVersion="1" change="p.Asp164fs">
            <Expression>NP_001288153.1:p.Asp164fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006383.4" sequenceAccession="NM_006383" sequenceVersion="4" change="c.476_479del" MANESelect="true">
            <Expression>NM_006383.4:c.476_479del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006374.1" sequenceAccession="NP_006374" sequenceVersion="1" change="p.Asp159fs">
            <Expression>NP_006374.1:p.Asp159fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_125435.2" sequenceAccession="NR_125435" sequenceVersion="2" change="n.684_687del">
            <Expression>NR_125435.2:n.684_687del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006383.4(CIB2):c.476_479del (p.Asp159fs) AND Usher syndrome type 1J" Accession="RCV003153285" Version="2">
        <ClassifiedConditionList TraitSetID="8953">
          <ClassifiedCondition DB="MedGen" ID="C3553944">Usher syndrome type 1J</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2023-02-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-02-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-03-26" MostRecentSubmission="2023-03-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23023331</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8953" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17417" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Usher syndrome type 1J</ElementValue>
                <XRef ID="MONDO:0013935" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">USH1J</ElementValue>
                <XRef ID="GTR000522776" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614869" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Usher syndrome type I (USH1) is characterized by congenital, bilateral, profound sensorineural hearing loss, vestibular areflexia, and adolescent-onset retinitis pigmentosa (RP). Unless fitted with a cochlear implant, individuals do not typically develop speech. RP, a progressive, bilateral, symmetric degeneration of rod and cone functions of the retina, develops in adolescence, resulting in progressively constricted visual fields and impaired visual acuity.</Attribute>
                <XRef ID="NBK1265" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15863" />
                <XRef ID="15863" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301442</ID>
                <ID Source="BookShelf">NBK1265</ID>
              </Citation>
              <XRef ID="231169" DB="Orphanet" />
              <XRef ID="886" DB="Orphanet" />
              <XRef ID="C3553944" DB="MedGen" />
              <XRef ID="MONDO:0013935" DB="MONDO" />
              <XRef Type="MIM" ID="614869" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7178720" SubmissionDate="2023-03-14" DateLastUpdated="2023-03-26" DateCreated="2023-03-26">
        <ClinVarSubmissionID localKey="3922|MedGen:C3553944" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003842247" DateUpdated="2023-03-26" DateCreated="2023-03-26" Type="SCV" Version="1" SubmitterName="Payam Genetics Center, General Welfare Department of North Khorasan Province" OrgID="508950" OrganizationCategory="clinic" OrgAbbreviation="PGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23023331</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Iranian</Ethnicity>
              <GeographicOrigin>Iran</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CIB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_006383.4:exon 4</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006383.4:c.476_479del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553944" Type="CUI" />
          </Trait>
        </TraitSet>
        <Comment>This sequence change create four nucleotides deletion frameshift (p.D159 fs) in the CIB2 gene. It is expected to result in an non-functional or disrupted protein product. Loss-of-function variants in CIB2 are known to be pathogenic (PMID:23023331). This variant is not present in population databases (gnomAD no frequency) and Iranian population genom( Iranom). This variant has not been reported in the literature in individuals affected with CIB2-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB12950626</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7178720" TraitType="Disease" MappingType="XRef" MappingValue="C3553944" MappingRef="MedGen">
        <MedGen CUI="C3553944" Name="Usher syndrome type 1J" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

